Cellectis (CLLS) Research & Development (2015 - 2026)
Cellectis (CLLS) reported Research & Development of -$24.98 million for Q2 2026, compared with -$23.08 million a year earlier.
Powered by 
Analysis
Cellectis (CLLS) Research & Development (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cellectis' Research & Development came in at -$100.67 million; for FY2025, it was -$93.52 million.
- By year, Research & Development came in at -$90.54 million in FY2024, -$87.65 million in FY2023, -$97.5 million in FY2022 and -$117.84 million in FY2021.
- Five-year quarterly Research & Development spans a low of -$34.32 million in Q3 2021 and a high of $25.63 million in Q2 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$27.19 million (Q1 2026), -$24.44 million (Q4 2025) and -$24.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.62 Bn | 1,103.20 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.94 Bn | 535.47 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.32 Bn | 474.43 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.44 Bn | 321.82 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.20 Bn | 262.19 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.78 Bn | 235.47 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.70 Bn | 191.10 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.88 Bn | 165.07 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Cellectis | 96.44 Mn | -656.96 Mn | - | -24.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.98 Mn |
| Mar 31, 2026 | -27.19 Mn |
| Dec 31, 2025 | -24.44 Mn |
| Sep 30, 2025 | -24.07 Mn |
| Jun 30, 2025 | 23.08 Mn |
| Mar 31, 2025 | -21.93 Mn |
| Dec 31, 2024 | 160.21 Mn |
| Sep 30, 2024 | -23.83 Mn |
| Jun 30, 2024 | 23.52 Mn |
| Mar 31, 2024 | -22.32 Mn |
| Dec 31, 2023 | 150.34 Mn |
| Sep 30, 2023 | -19.08 Mn |
| Jun 30, 2023 | 22.20 Mn |
| Mar 31, 2023 | -21.42 Mn |
| Dec 31, 2022 | -21.43 Mn |
| Sep 30, 2022 | -23.84 Mn |
| Jun 30, 2022 | 25.63 Mn |
| Mar 31, 2022 | -26.60 Mn |
| Dec 31, 2021 | -29.54 Mn |
| Sep 30, 2021 | -34.32 Mn |
API Access
Cellectis Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();